Advances in Drug and Gene Delivery Strategies: Revolutionizing Breast Cancer Therapy

Breast cancer is a global health challenge, demanding innovative therapeutic approaches to improve patient outcomes. Nanotechnology has emerged as a promising avenue, facilitating targeted drug delivery to breast cancer cells while minimizing off-target effects. Nanoparticle-based formulations, including liposomes, polymeric nanoparticles and lipid-based nanoparticles offer precise control over drug release kinetics and enhanced bioavailability. Furthermore, gene delivery platforms have garnered attention for their potential to modulate gene expression and overcome drug resistance mechanisms in breast cancer. Moreover, the integration of innovative technologies, like CRISPR-Cas9 gene editing and RNAi, holds promise for targeted gene manipulation and personalized treatment approaches in cancer therapy.